Connect with us

Hi, what are you looking for?

Editor's Pick

Egypt begins vaccine rollout to wider population

World54 minutes ago (Mar 04, 2021 05:31AM ET)

5/5

(C) Reuters. Egypt begins vaccine rollout

2/5

CAIRO (Reuters) – Egypt on Thursday expanded its coronavirus vaccination rollout to include the elderly and people with chronic diseases after several weeks of vaccinating medical staff, the cabinet said.

Nearly 153,000 people have applied for vaccinations since Sunday when the North African country opened online registration, the cabinet said in a statement.

Egypt, the Arab world’s most populous country with more than 100 million, has prepared 40 vaccination centres and plans to increase that number after the arrival of more vaccine batches, Prime Minister Mostafa Madbouly said.

Egypt received 350,000 doses of a coronavirus vaccine? ? developed by China National Pharmaceutical Group (Sinopharm) in two batches since December, in addition to 50,000 doses of a vaccine developed by AstraZeneca (NASDAQ:AZN) in February.

It is hoping to receive vaccines through the COVAX facility, a global initiative aimed at providing equitable distribution of vaccines, in the coming weeks.

On Feb. 24, the Egyptian Drug Authority approved Russia’s Sputnik V vaccine for emergency use. Egypt’s Prime Speed Medical Services said it had obtained the right to provide Sputnik V in Egypt in a statement to the stock exchange, without giving details.

Egypt began vaccinating frontline medical staff against COVID-19 on Jan. 24 using the Chinese vaccine.

Those getting the Sinopharm jab have a second dose after 21 days while those who receive the AstraZeneca vaccine wait 12 weeks for the second dose, said Health Minister Hala Zayed.

As of Wednesday, Egypt had confirmed 184,168 coronavirus cases, including 10,822 deaths, since the start of the pandemic.

However, health officials say the real number is likely far higher due to a relatively low rate of coronavirus testing and the exclusion of private test results.

Egypt begins vaccine rollout to wider population

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Uncategorized

Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora incidunt.

Uncategorized

Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione.

Uncategorized

Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem eum.

Uncategorized

Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora.

Disclaimer: Buzzclever.com it's managers and its employees (collectively "The Company") do not make any guarantee or warranty about what is advertised or above. Information provided by this website is for research purposes only and should not be considered as personalized financial or health advice. Copyright © 2021 Buzz Clever. All Rights Reserved